These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4089735)

  • 1. [Morphology and cytochemistry in the diagnosis of myelodysplastic syndromes].
    Villegas A; Guerra JL; del Potro E; Espinós D
    Sangre (Barc); 1985; 30(4-C):638-50. PubMed ID: 4089735
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biology and clinical aspects of primary myelodysplastic syndromes].
    Urbańska-Ryś H; Robak T; Krykowski E
    Pol Tyg Lek; 1988 Feb; 43(7):225-9. PubMed ID: 3043403
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bone marrow histology in myelodysplastic syndromes].
    Frisch B; Bartl R
    Harefuah; 1987 Jan; 112(1):1-3. PubMed ID: 3609917
    [No Abstract]   [Full Text] [Related]  

  • 4. Biologic and clinical implications of marrow culture studies in the myelodysplastic syndromes.
    Greenberg PL
    Semin Hematol; 1996 Apr; 33(2):163-75. PubMed ID: 8722686
    [No Abstract]   [Full Text] [Related]  

  • 5. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myelodysplastic syndromes--diagnostic and therapeutic problems].
    Skotnicki AB; Piatkowska-Jakubas B; Rucińska M; Zduńczyk A
    Przegl Lek; 1988; 45(11):801-11. PubMed ID: 3072594
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myelodysplastic syndromes].
    Raza A; Vadhan-Raj S; Chávez-Sánchez G
    Rev Invest Clin; 1997 May; 49 Suppl 1():15-21. PubMed ID: 9380984
    [No Abstract]   [Full Text] [Related]  

  • 8. [Delimitation of the concept, nosology and classification of myelodysplastic syndromes].
    Sans-Sabrafen J; Woessner S
    Sangre (Barc); 1985; 30(4-C):633-7. PubMed ID: 4089734
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myelodysplastic syndromes].
    Matsuda A
    Rinsho Ketsueki; 2009 Mar; 50(3):147-53. PubMed ID: 19352080
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS).
    Cantù Rajnoldi A; Fenu S; Kerndrup G; van Wering ER; Niemeyer CM; Baumann I;
    Ann Hematol; 2005 Jul; 84(7):429-33. PubMed ID: 15838669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphology and classification of myelodysplastic syndromes.
    Kouides PA; Bennett JM
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):485-99. PubMed ID: 1613002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndrome: from morphology to biology.
    Albitar M; Zhou W; Giles F
    Curr Hematol Rep; 2004 May; 3(3):159-64. PubMed ID: 15087062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New cognition of diagnosis and classification in myelodysplastic syndromes].
    Pu Q
    Zhonghua Nei Ke Za Zhi; 1999 Jun; 38(6):365-7. PubMed ID: 12795293
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional disturbances in hemopoietic microenvironment in various forms of myelodysplastic syndrome.
    Manakova T; Gerasimova L; Tsvetaeva N; Momotyuk K
    Bull Exp Biol Med; 2000 Sep; 130(9):832-4. PubMed ID: 11177256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topics in bone marrow biopsy pathology: role of marrow topography in myelodysplastic syndromes and evaluation of post-treatment and post-bone marrow transplant biopsies.
    Reddy VV
    Ann Diagn Pathol; 2001 Apr; 5(2):110-20. PubMed ID: 11294998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow cell kinetics in primary myelodysplastic syndromes.
    Montecucco C; Riccardi A; Ascari E
    Haematologica; 1987; 72(6 Suppl):132-4. PubMed ID: 3127290
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bone marrow biopsy in the study of myelodysplastic syndromes].
    Hernández Nieto L; Brito Barroso ML; Marsá Vilá L; González Brito G; Batista López JN; Ravina M; Rodríguez Martín JM
    Sangre (Barc); 1985; 30(4-C):680-8. PubMed ID: 4089738
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone marrow stroma in childhood myelodysplastic syndrome: composition, ability to sustain hematopoiesis in vitro, and altered gene expression.
    Borojevic R; Roela RA; Rodarte RS; Thiago LS; Pasini FS; Conti FM; Rossi MI; Reis LF; Lopes LF; Brentani MM
    Leuk Res; 2004 Aug; 28(8):831-44. PubMed ID: 15203281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the MEK inhibitor CI-1040 (PD 184352) on progenitor growth from normal and myelodysplastic marrow.
    Steensma DP; Mesa RA; Reeder TL; Tefferi A; Kaufmann SH
    Haematologica; 2003 Sep; 88(9):1072-4. PubMed ID: 12969818
    [No Abstract]   [Full Text] [Related]  

  • 20. Constant detection of cyclooxygenase 2 in terminal stages of myeloid maturation.
    Tripodo C; Florena AM; Porcasi R; Ingrao S; Guarnotta C; Franco V
    Acta Haematol; 2007; 117(1):48-50. PubMed ID: 17095859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.